05:25 AM EDT, 09/15/2026 (MT Newswires) -- Imaging Biometrics' (IBAI.L) US-based subsidiary, Imaging Biometrics LLC, signed an annual subscription agreement with a regional healthcare system for access to its advanced brain tumor imaging platform. The transaction marks the healthcare technology group's second major new installation in the third quarter and covers its quantitative neuro-oncology imaging software, including IB Neuro, IB Delta T1, and IB FTBx, according to a Tuesday filing.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.